Replies to post #372 on Genova Biotherapeutics, Inc.(fka GVBP)

[The_Free_Nebula]

Some more Spam...I wonder how many folks got this...proceed with your eyes open

Hi everyone,

As promised I am filling you in on EVERYTHING regarding GENova.

As you know, GVBP closed up 85% today on tremedous volume, around 58,000,000 traded to be exact.
GVBP is the #1 most traded smallcap biotech in the world right now, it had 8,161 individual trades today alone!

Individuals and institutions are buying up GVBP as if they seem to know that something is up.
Sure enough HGSI and VNDA, both biotechs, soared from 0.45 to 20 bucks, and 0.45 to 13 dollars respectively.

GVBP seems to be following the same upward pattern as them and still has a BUY recommendation by GrassRoots Research analysts.

Congratulations to everyone who's made a profit so far, and as I have just said the company seems to have a ton of room to grow and possibly reach shareprices similar to VNDA and HGSI.

GVBP has been releasing huge news left and right. Today was no different with two big PRS!

In the first press release GVBP announced that they have gained access to distribution channels for its promising drug targets through a recently-signed deal with Bridge BioResearch Plc.

In the second PR GVBP announced that they have signed an LOI with Prime BioResearch, another drug acquisition company in the areas of drug development and distribution.


At .80 cents, I consider GVBP to still be a HUGE BARGAIN!


GENova Biotherapeutics :

Is rapidly building its portfolio of proprietary biotechnology.
Is Targeting a neach market based on recent discoveries that indicate that most tumors are derived from a single cancer-initiating cell population which has stem cell properties (a cancer stem cell).
Has chosen to focus on the identification of certain cell-specific characteristics, making it possible to identify precursor cells of tumors, and then conduct a more extensive 'fingerprinting' profile that will enable the development of cell-specific anti-cancer treatments.
Is seeking FDA approval in the short-term in order to make the drugs available for the USA



Earlier this year President Obama overturned the Bush policy on stem cell research and has lifted the ban on federal funding of promising stem cell research! Quoting the president, "Medical miracles do not happen simply by accident,"


GVBP's new stem cell identification technology could truly cure prostate and breast cancer once and for all!



Keep watching GVBP as it breaks all-time highs over and over again.
It is so far my best pick ever!

Thank you,
Your CrazyPennyStocks Editor.

[medchal]

Wow, those crazypennystock guys, huh? Of course the editor is obsessed with GVBP:

 Company:  	Genova Biotherapeutics Inc.( GVBP)  	 Promoter:  	 Crazy penny Stock 
 9/11/2009 
 End of Day: 	$ Close: 	0.290 	Volume: 	73,966,581 
   	$ Change: 	 0.067 	% Change: 	30.045 
 3 Month : 	$ High: 	0.290 	Volume 3m : 	5,033,053 
   	$ Low: 	0.030 	% Change 3m : 	12.441 
 Compensation: 	fifty five thousand dollars 
 Company: 	Genova Biotherapeutics Inc.( GVBP) 	Promoter: 	Crazy penny Stock 
 9/10/2009 
 End of Day: 	$ Close: 	0.223 	Volume: 	22,838,746 
   	$ Change: 	 0.038 	% Change: 	20.541 
 3 Month : 	$ High: 	0.250 	Volume 3m : 	3,005,596 
   	$ Low: 	0.030 	% Change 3m : 	11.924 
 Compensation: 	Fifty five thousand dollars

Now, was that one or two $55,000 payments for promotion? Ah, who cares? What's $55,000 among friends?

And just look what that gets you:

"GVBP is seeking FDA approval at the moment." - A baldfaced lie. The F. D. A. doesn't know GENova exists, and GENova has absolutely nothing before the F. D. A.

"GVBP has multimillion dollar contracts." Only with stock promoters (if you add them all together)!

"GVBP has the most amazing staff a biotech can ask for." What, three people? Four?

[Stock]

I'ts interesting that email spam has made such a comeback lately.

I wonder where they got their list?